Search

everythinglearnresearchcommunity

for

Search:↓

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

Reducing gefitinib dosage improved hair loss, but scarring remained.

The AVET system effectively delivers genes to human keratinocytes and may help treat skin diseases.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

The Bethesda system is effective for identifying thyroid cancer but has low sensitivity.

A new method improves betulin delivery and shows promise in cancer treatment.

The most common sign of aging at the gene level is more Ectodysplasin A2 Receptor (EDA2R) being made.

The TLMG hydrogel improves wound healing and monitoring with strong adhesion and conductivity.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

The emulgel with specific ingredients was effective for treating hair loss.

The reconstructed skin model from hair follicles functions like human skin in processing chemicals and can be used to test ingredient safety.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Injections of special skin cells showed potential in treating hair loss, with some participants experiencing increased hair density.

The serum with microneedling effectively treats alopecia areata by enhancing drug delivery and is safe and patient-friendly.

Lecithin-encapsulated resveratrol nanoparticles could be a safe and effective anti-cancer treatment.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Topical tacalcitol ointment can help improve symptoms of EFFC.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

A woman with hypothyroidism developed an allergy to IV levothyroxine after being resistant to oral forms.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

New therapy helps treat hair loss.

The new treatment using nanoparticles with ISX9 can effectively regrow hair without major side effects.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Eplerenone, a mineralocorticoid receptor antagonist, was found to promote hair growth in human hair follicles.

Eflornithine HCl 13.9% cream is safe for skin use with mild, temporary irritation.